Simulations Plus(NASDAQ:SLP) Declares Dividend of $0.0500.

Simulations Plus (NASDAQ:SLP) had declared a cash dividend of $0.0500 on Aug 1, 2016. The shares will quote ex-dividend on Aug 9, 2016 and the record date has been fixed for Aug 11, 2016. On Aug 1, 2016 share price, the yield comes out to be 2.4969%. The dividend payable date has been fixed on Aug 18, 2016.

Simulations Plus (SLP) made into the market gainers list on Mondays trading session with the shares advancing 0.36% or 0.03 points. Due to strong positive momentum, the stock ended at $8.26, which is also near the day’s high of $8.33. The stock began the session at $8.24 and the volume stood at 36,689 shares. The 52-week high of the shares is $11.8899 and the 52 week low is $6.08. The company has a current market capitalization of $141 M and it has 1,70,51,964 shares in outstanding.

Simulations Plus(SLP) last announced its earnings results on Jul 14, 2016 for Fiscal Year 2016 and Q3.Company reported revenue of $6.01M. Analysts had an estimated revenue of $6.57M. Earnings per share were $0.11. Analysts had estimated an EPS of $0.12.

Several Insider Transactions has been reported to the SEC. On Feb 2, 2016, Walter S Woltosz (CEO) sold 58,181 shares at $11.27 per share price.

Simulations Plus Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption Distribution Metabolism Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption pharmacokinetics and pharmacodynamics of drugs.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Simulations Plus - Is it time to Sell?

Top Brokerage Firms are advising their investors on Simulations Plus. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.